These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 10188635)

  • 1. Modulation of GABA release by dopamine in the substantia nigra.
    Matuszewich L; Yamamoto BK
    Synapse; 1999 Apr; 32(1):29-36. PubMed ID: 10188635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of AMPA and D1 receptor activation on striatal and nigral GABA efflux.
    Byrnes EM; Reilly A; Bruno JP
    Synapse; 1997 Jul; 26(3):254-68. PubMed ID: 9183815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between dopamine D1 receptors and gamma-aminobutyric acid mechanisms in substantia nigra pars reticulata of the rat: neurochemical and behavioral studies.
    Trevitt T; Carlson B; Correa M; Keene A; Morales M; Salamone JD
    Psychopharmacology (Berl); 2002 Jan; 159(3):229-37. PubMed ID: 11862355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GABA(B) receptor activation inhibits dopamine D1 receptor-mediated facilitation of [(3)H]GABA release in substantia nigra pars reticulata.
    Nava-Asbell C; Paz-Bermudez F; Erlij D; Aceves J; Florán B
    Neuropharmacology; 2007 Oct; 53(5):631-7. PubMed ID: 17868750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opposing roles of dopamine D1 and D2 receptors in nigral gamma-[3H]aminobutyric acid release?
    Starr M
    J Neurochem; 1987 Oct; 49(4):1042-9. PubMed ID: 2957468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in extracellular levels of glutamate and aspartate in rat substantia nigra induced by dopamine receptor ligands: in vivo microdialysis studies.
    Abarca J; Gysling K; Roth RH; Bustos G
    Neurochem Res; 1995 Feb; 20(2):159-69. PubMed ID: 7783840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of methylenedioxymethamphetamine-induced striatal dopamine release by the interaction between serotonin and gamma-aminobutyric acid in the substantia nigra.
    Yamamoto BK; Nash JF; Gudelsky GA
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1063-70. PubMed ID: 7791076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substantia nigra D1 receptors and stimulation of striatal cholinergic interneurons by dopamine: a proposed circuit mechanism.
    Abercrombie ED; DeBoer P
    J Neurosci; 1997 Nov; 17(21):8498-505. PubMed ID: 9334422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of dopaminergic and GABAergic neurotransmission: impact of 6-hydroxydopamine lesions into the substantia nigra of rats.
    Hossain MA; Weiner N
    J Pharmacol Exp Ther; 1995 Oct; 275(1):237-44. PubMed ID: 7562556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopaminergic regulation of extracellular gamma-aminobutyric acid levels in the prefrontal cortex of the rat.
    Grobin AC; Deutch AY
    J Pharmacol Exp Ther; 1998 Apr; 285(1):350-7. PubMed ID: 9536031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine control of seizure propagation: intranigral dopamine D1 agonist SKF-38393 enhances susceptibility to seizures.
    Turski WA; Cavalheiro EA; Ikonomidou C; Bortolotto ZA; Klockgether T; Turski L
    Synapse; 1990; 5(2):113-9. PubMed ID: 2137942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-injurious behavior and dopaminergic neuron system in neonatal 6-hydroxydopamine-lesioned rat: 2. Intracerebral microinjection of dopamine agonists and antagonists.
    Okamura H; Murakami T; Yokoyama C; Nakamura T; Ibata Y
    J Pharmacol Exp Ther; 1997 Feb; 280(2):1031-7. PubMed ID: 9023320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of NMDA and MK-801 injected into the substantia nigra pars reticulata on jaw movements evoked by dopamine D1-/D2 receptor stimulation in the ventrolateral striatum: studies in freely moving rats.
    Uchida T; Lee J; Fujita S; Kiguchi M; Matsumoto M; Oi Y; Gionhaku N; Koshikawa N
    Methods Find Exp Clin Pharmacol; 2005; 27(1):31-7. PubMed ID: 15834457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrical stimulation of the substantia nigra reticulata: detection of neuronal extracellular GABA in the ventromedial thalamus and its regulatory mechanism using microdialysis in awake rats.
    Timmerman W; Westerink BH
    Synapse; 1997 May; 26(1):62-71. PubMed ID: 9097406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurophysiological investigation of effects of the D-1 agonist SKF 38393 on tonic activity of substantia nigra dopamine neurons.
    Carlson JH; Bergstrom DA; Weick BG; Walters JR
    Synapse; 1987; 1(5):411-6. PubMed ID: 2975067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of full D1 dopamine receptor agonists on firing rates in the globus pallidus and substantia nigra pars compacta in vivo: tests for D1 receptor selectivity and comparisons to the partial agonist SKF 38393.
    Ruskin DN; Rawji SS; Walters JR
    J Pharmacol Exp Ther; 1998 Jul; 286(1):272-81. PubMed ID: 9655869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurotensin-dopamine interactions in the substantia nigra of the rat brain.
    Merchant KM; Bush LG; Gibb JW; Hanson GR
    J Pharmacol Exp Ther; 1990 Nov; 255(2):775-80. PubMed ID: 2147039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopaminergic and GABAergic modulation of glutamate release from rat subthalamic nucleus efferents to the substantia nigra.
    Hatzipetros T; Yamamoto BK
    Brain Res; 2006 Mar; 1076(1):60-7. PubMed ID: 16680828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SKF 38393 alters the rate-dependent D2-mediated inhibition of nigrostriatal but not mesoaccumbens dopamine neurons.
    Kelland MD; Freeman AS; Chiodo LA
    Synapse; 1988; 2(4):416-23. PubMed ID: 2973142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D4 and D1 dopamine receptors modulate [3H] GABA release in the substantia nigra pars reticulata of the rat.
    Acosta-García J; Hernández-Chan N; Paz-Bermúdez F; Sierra A; Erlij D; Aceves J; Florán B
    Neuropharmacology; 2009 Dec; 57(7-8):725-30. PubMed ID: 19715708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.